ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 249 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $19,610,000 | -28.5% | 698,859 | -13.4% | 0.41% | -21.3% |
| Q3 2021 | $27,422,000 | -34.8% | 806,769 | -21.6% | 0.52% | -30.3% |
| Q2 2021 | $42,049,000 | +1.9% | 1,029,114 | +0.4% | 0.75% | -4.7% |
| Q1 2021 | $41,250,000 | -30.0% | 1,024,583 | +2.7% | 0.78% | -24.1% |
| Q4 2020 | $58,967,000 | +22.2% | 997,249 | +0.5% | 1.03% | +6.5% |
| Q3 2020 | $48,272,000 | +28.3% | 992,639 | +27.7% | 0.97% | +8.0% |
| Q2 2020 | $37,620,000 | +105.6% | 777,590 | +18.1% | 0.90% | +30.2% |
| Q1 2020 | $18,298,000 | +89.5% | 658,650 | +104.1% | 0.69% | +92.5% |
| Q4 2019 | $9,654,000 | – | 322,660 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |